HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

No-Reflow Phenomenon

Markedly reduced or absent REPERFUSION in an infarct zone following the removal of an obstruction or constriction of an artery.
Also Known As:
Slow-Flow Phenomenon; No Reflow Phenomenon; Phenomenon, Slow-Flow; Slow Flow Phenomenon
Networked: 370 relevant articles (21 outcomes, 51 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Thrombosis (Thrombus)
2. Myocardial Infarction
3. Ischemia
4. Hypercholesterolemia
5. Coronary Artery Disease (Coronary Atherosclerosis)

Experts

1. Kang, Jung Chaee: 5 articles (07/2013 - 10/2004)
2. Hong, Young Joon: 5 articles (07/2013 - 10/2004)
3. Jeong, Myung Ho: 5 articles (07/2013 - 10/2004)
4. Beltrame, John F: 4 articles (05/2014 - 01/2002)
5. Kim, Kye Hun: 4 articles (07/2013 - 10/2004)
6. Park, Jong Chun: 4 articles (07/2013 - 10/2004)
7. Kim, Ju Han: 4 articles (07/2013 - 10/2004)
8. Cho, Jeong Gwan: 4 articles (07/2013 - 10/2004)
9. Park, Hyung Wook: 4 articles (07/2013 - 10/2004)
10. Ahn, Youngkeun: 4 articles (07/2013 - 08/2007)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to No-Reflow Phenomenon:
1. Verapamil (Calan)FDA LinkGeneric
2. Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
3. AdenosineFDA LinkGeneric
4. Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric
5. OxygenIBA
6. Nitric Oxide (Nitrogen Monoxide)FDA Link
7. Adenosine Triphosphate (ATP)IBA
8. eptifibatide (Integrilin)FDA Link
9. yiki-huoxueIBA
10. abciximab (ReoPro)FDA Link

Therapies and Procedures

1. Transplants (Transplant)
2. Angioplasty (Angioplasty, Transluminal)
3. Coronary Atherectomy
4. Stents
5. Replantation